Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.sigachi.com | |
Market Cap | 735.21 Cr. | |
Enterprise Value(EV) | 750.64 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 15.57 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 15.41 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 26.46 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 85.87 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 2.79 | Calculated using Price: 239.95 |
Dividend Yield | 0.42 | Period Ending 2022-03 |
No. of Shares Subscribed | 3.07 Cr. | 30,742,500 Shares |
FaceValue | 10 | |
Company Profile | ||
The company is an industry leader in the field of Pharma Excipients, Nutra and food ingredients. The company has rapidly established itself as one of the largest manufacturers of Microcrystalline Cellulose worldwide. |
1 Day |
|
-0.17% |
1 Week |
|
-4.40% |
1 Month |
|
-7.30% |
3 Month |
|
-5.27% |
6 Month |
|
-12.32% |
1 Year |
|
-19.44% |
2 Year |
|
|
5 Year |
|
|
10 Year |
|
5 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 26.28 | 53.39 | 37.12 | 38.11 | 24.87 | |
Return on Capital Employed (%) | 23.60 | 44.44 | 33.55 | 37.83 | 27.93 | |
Return on Assets (%) | 9.58 | 23.22 | 20.25 | 24.95 | 19.06 |
Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 26 | 45 | 65 | 94 | 228 | 250 | |
Non Curr. Liab. | 6 | 4 | 5 | 7 | 8 | 29 | |
Curr. Liab. | 40 | 42 | 39 | 32 | 51 | 73 | |
Minority Int. | |||||||
Equity & Liab. | 72 | 91 | 109 | 133 | 287 | 353 | |
Non Curr. Assets | 28 | 32 | 37 | 46 | 107 | 188 | |
Curr. Assets | 44 | 59 | 72 | 87 | 180 | 164 | |
Misc. Exp. not W/O | |||||||
Total Assets | 72 | 91 | 109 | 133 | 287 | 353 |
Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 101 | 129 | 139 | 193 | 250 | 302 | |
Other Income | 3 | 4 | 5 | 3 | 3 | 7 | |
Total Income | 104 | 133 | 144 | 196 | 253 | 309 | |
Total Expenditure | -89 | -103 | -114 | -154 | -197 | -241 | |
PBIDT | 15 | 30 | 30 | 42 | 56 | 68 | |
Interest | -4 | -3 | -2 | -1 | -1 | -3 | |
Depreciation | -1 | -2 | -2 | -2 | -3 | -5 | |
Taxation | -3 | -6 | -5 | -8 | -12 | -11 | |
Exceptional Items | |||||||
PAT | 7 | 19 | 20 | 30 | 40 | 48 | |
Minority Interest | |||||||
Share Associate | |||||||
Other Related Items | |||||||
Consolidated Net Profit | 7 | 19 | 20 | 30 | 40 | 48 | |
Adjusted EPS | 23 | 62 | 26 | 13 | 13 | 16 |
Particulars | 5 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 6 | 14 | 12 | 30 | 6 | |
Cash Fr. Inv. | -4 | -6 | -7 | -11 | -63 | |
Cash Fr. Finan. | -3 | -9 | 3 | -11 | 108 | |
Net Change | -1 | 0 | 8 | 7 | 51 | |
Cash & Cash Eqvt | 3 | 2 | 11 | 18 | 69 |
Fri, 17 Feb 2023
3Rd EGM-Transcript 3rd EGM-Transcript |
Thu, 16 Feb 2023
Announcement under Regulation 30 (LODR)-Resignation of Director Resignation of Independent Director |
Tue, 14 Feb 2023
Announcement under Regulation 30 (LODR)-Monitoring Agency Report Q3 Monitoring Agency Report |
Fri, 24 Mar 2023 |
|
|
|
|
|